leisure time -WSS

leisure time

author：hotspot 2025-09-29 01:06:40 - browse：4

Cathy McMorris Rodgers -- health policy coverage from STAT — Rep. Cathy McMorris Rodgers announced her plans to leave Congress at the end of 2024. Anna Moneymaker/Getty Images

WASHINGTON — Rep. Cathy McMorris Rodgers, the chair of a crucial House committee that handles health care issues, plans to leave Congress at the end of the year, she announced Thursday.

It will be a major shakeup for a panel already ravaged by Republican retirements. Reps. Michael Burgess (R-Texas), Larry Bucshon (R-Ind.), Jeff Duncan (R-S.C.), Debbie Lesko (R-Ariz.), Greg Pence (R-Ind.) and Kelly Armstrong (R-N.D.) are all leaving at the end of this Congress, too.

Under McMorris Rodgers, the panel led the way for House passage of a health care price transparency package that included the first major proposal to equalize payment between hospital outpatient departments and physician offices.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Medicare to cover more brain scans for Alzheimer’s patients

knowledge

WSS

WHO calls for emergency meeting on new China virus, as cases spread

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Close Medicare's dangerous gaps in addiction treatment coverage

Medicare has a new plan to address drug shortages

Orangutan used medicinal plant to treat wound, first time ever seen

MultiPlan and major insurers sued for alleged medical price

focus

leisure time

explore

The high cost of giving birth even with insurance

Getting Alzheimer's drug Leqembi to patients can be a challenge

Trump demands the U.S. pay no more for drugs than other countries … again

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

ChatGPT in medicine: STAT answers readers' burning questions

Element Biosciences CEO lays out genome sequencing strategy

Apple is now the first public company to be valued at $3 trillion

Getting Alzheimer's drug Leqembi to patients can be a challenge

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

hotspot

Cosmetics set for new safety regulation. Why the industry is on board

More tobacco lobbyists active in statehouses

Diversity in clinical trials starts with building trust, experts say

Melinda French Gates resigns from Gates Foundation

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Cell therapy fails to slow type 1 diabetes, but safety is established

Wikipedia

explore

knowledge

hotspot